-
Product Insights
Hemoglobinuria – Drugs In Development, 2023
Global Markets Direct’s, ‘Hemoglobinuria - Drugs In Development, 2023’, provides an overview of the Hemoglobinuria pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hemoglobinuria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Paroxysmal Nocturnal Hemoglobinuria – Drugs In Development, 2023
Global Markets Direct’s, ‘Paroxysmal Nocturnal Hemoglobinuria - Drugs In Development, 2023’, provides an overview of the Paroxysmal Nocturnal Hemoglobinuria pipeline landscape. The report provides comprehensive information on the therapeutics under development for Paroxysmal Nocturnal Hemoglobinuria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) – Drugs In Development, 2023
Global Markets Direct’s, ‘Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Drugs In Development, 2023’, provides an overview of the Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the...
-
Sector Analysis
Vacation Rental Market, Trends and Analysis by Region and Country Forecasts to 2030
The ‘Vacation Rental Market’ report provides in-depth analysis and market insights that will you: Make informed decisions about investments, partnerships, and product development in the vacation rental market. Assess the competitive dynamics by identifying the major market players. Evaluate the potential growth opportunities and trends in market segments to expand the product portfolio. Foresee possible changes in the market dynamics and align business strategies to capitalize on them. Identify potential areas of disruption. How is our ‘Vacation Rental Market’ report different from other...
-
Product Insights
Cardiac Valve Repair – Abbott Laboratories – ATTUNE
GlobalData, the industry analysis specialist, has released its latest report: Cardiac Valve Repair - Abbott Laboratories - ATTUNE. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Product Insights
Knee Reconstruction – DePuy Synthes Inc – ATTUNE
GlobalData, the industry analysis specialist, has released its latest report: Knee Reconstruction - DePuy Synthes Inc - ATTUNE. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Product Insights
Knee Reconstruction – DePuy Synthes Inc – ATTUNE REV
GlobalData, the industry analysis specialist, has released its latest report: Knee Reconstruction - DePuy Synthes Inc - ATTUNE REV. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
Knee Reconstruction – DePuy Synthes Inc – ATTUNE RP
GlobalData, the industry analysis specialist, has released its latest report: Knee Reconstruction - DePuy Synthes Inc - ATTUNE RP. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Company Profile
DePuy Synthes Inc – Company Profile
DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic procedures. The company offers orthopedic products and services in the areas of trauma, joint reconstruction, spine, sports medicine, cranio-maxillofacial, power tools and biomaterials. Its major products include Attune revision knee system, which enable surgeons to manage primary and revision knee procedures. The company offers its products to physicians, hospitals, surgeons, and caregivers, among others. The company distributes products in...
Add to Basket -
Product Insights
Attune Medical, United States Revenue
GlobalData, the industry analysis specialist, has released its latest report: Attune Medical, United States Revenue. The medical devices sector is typified by frequent change and innovation in available devices, in response to demand from healthcare for ever more effective therapies and increased competition. As a result, the sector has seen the emergence of start-up medtech companies who are producing the most innovative and cutting-edge solutions to problems and issues faced by the healthcare industry. Most of these companies are private...